Image

Surgical-imaging Research on Obesity (SIRO)

Surgical-imaging Research on Obesity (SIRO)

Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

The global obesity epidemic is well established, and is an important public health issue. The previous researches had applied the clues that obesity is a kind of systemic disease. The investigators hypothesized that a serious alteration of the body systems will occur after bariatric surgery, which may shed light on the mechanisms of obesity. Thus, the research aims to combine the imaging and surgery to investigate the alterations of the body that induced by obese and alterations after surgery.

Description

In 2016, the prevalence of obesity has already reached 13% of obesity and about 40% overweight worldwide. There is no doubt that obesity is linked to a broad spectrum of diseases,such as cardiovascular diseases, fatty liver diseases, polycystic ovarian syndrome and even central nervous systems disorders. For instance, in a review, author indicated the insulin resistance of T2DM occurs primarily in the muscles of lean individuals before they become obese. The central nervous system, especially the hypothalamus, has always considered to be the regulation center of food intake and hormonal regulation of energy homeostasis. In turn, obesity may worsen the regularity function of nervous system in several pathway. Based on the previous findings, the investigators hypothesized that a serious alterations of the body systems will occur after bariatric surgery, which may shed light on the mechanisms of obesity. The investigators plan to integrate the MR imaging, biological and epidemiological data thoroughly to investigate the alterations of the body that induced by obese and also followup the alterations that after surgery.

Eligibility

Inclusion Criteria for obesity group:

        Meeting the obesity criteria (BMI > 28); 2) Meeting the indications for bariatric surgery,
        planning to undergo surgery for the first time; 3) Age between 18-65 years old, no gender
        restrictions; 4) Right-handed, of Han ethnicity; 5) Informed consent to the study, willing
        to cooperate with the research, and able to sign an informed consent form.
        Inclusion Criteria for the Control Group:
          1. Healthy volunteers with a BMI between 18.5-23.9;
          2. Age between 18-65 years old, no gender restrictions;
          3. Right-handed, of Han ethnicity;
          4. Informed consent to the study, willing to cooperate with the research, and able to
             sign an informed consent form.
        Exclusion Criteria for obesity group:
          1. Secondary obesity caused by other organic diseases or medication (such as hormone use,
             etc.);
          2. Unable to undergo surgery as planned;
          3. Pregnant or breastfeeding;
          4. Low cognitive ability and incapable of cooperating with the study;
          5. Eating disorders;
          6. Alcohol or drug dependence;
          7. Meeting the criteria for organic mental disorders, severe mental disorders
             (schizophrenia, etc.), or other serious mental illnesses requiring clinical
             intervention;
          8. Contraindications for MR scanning (pacemakers, cochlear implants, metal objects in the
             body, claustrophobia, weight exceeding the machine's load limit, etc.);
          9. History of neurological organic diseases (brain tumors, epilepsy, cerebrovascular
             accidents, severe head trauma, etc.);
         10. History of congenital heart disease (myocardial infarction, severe arrhythmias, heart
             failure, cardiomyopathy, rheumatic heart disease, congenital heart disease, etc.);
         11. Severe liver, kidney, lung, digestive dysfunction, endocrine, and blood system
             diseases;
         12. Active infections within the last two weeks (fever, upper respiratory infection, acute
             gastroenteritis, etc.);
         13. Use of drugs affecting the nervous system or psychotropic drugs within the last six
             months.
        Exclusion Criteria for the Control Group:
        The same criteria as points 3) to 13) above.

Study details
    Overweight and Obesity

NCT06268262

The Affiliated Hospital of Xuzhou Medical University

20 March 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.